Position in DXCM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,092,397
-$326,188 QoQ
Shares Held
49,242
-4.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $45,284,146 across 37 Medical Devices names. DXCM ranks #3 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
171,568 | $10,765,891 | |
| 2 | PODD |
Insulet Corp
|
21,574 | $4,527,088 | |
| 3 | DXCM |
Dexcom Inc
This page
|
49,242 | $3,092,397 | |
| 4 | SYK |
Stryker Corp
|
8,157 | $2,680,308 | |
| 5 | EW |
Edwards Lifesciences Corp
|
33,116 | $2,651,928 | |
| 6 | ESTA |
Establishment Labs Holdings Inc.
|
43,726 | $2,482,762 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
16,787 | $1,981,201 | |
| 8 | MASI |
Masimo Corp
|
10,628 | $1,890,402 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,092,397 | 49,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,418,585 | 51,508 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,785,270 | 26,531 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $431,125 | 4,939 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $260,529 | 3,350 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $1,559,190 | 12,565 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $274,955 | 2,947 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||